Elevated Vascular Endothelial Growth Factor in Keloids: Relevance to Tissue Fibrosis

Cells Tissues Organs

Volumn 176, Issue 1-3, 2004, Pages 87-94

  Le, Anh D ^a,b   Zhang, Qunzhou ^a   Wu, Yidi ^a   Messadi, Diana V ^b   Akhondzadeh, Anita ^a   Nguyen, Andrew L ^a   Aghaloo, Tara L ^b   Kelly, A Paul ^a   Bertolami, Charles N ^c  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extracellular matrix; Fibrosis; Hypoxia inducible factor 1 ; Keloids; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DISEASE DURATION; EXTRACELLULAR MATRIX; FIBROSIS; INFLAMMATION; KELOID; METABOLISM; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE INJURY; WOUND HEALING;

DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; KELOID; NUCLEAR PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 1042289600     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075030     Document Type: Conference Paper

References (70)

1. Aiello, L.P., R.L. Avery, P.G. Arrigg, B.A. Keyt, H.D. Jampel, S.T. Shah, L.R. Pasquale, H. Thieme, M.A. Iwamoto, J.E. Park, H.V. Nguyen, L.E. Aiello, N. Ferrara, G.L. King (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorder. N Engl J Med 331: 1480-1487.
2. Akimoto, S., O. Ishikawa, C. Iijima, Y. Miyachi (1999) Expression of basic fibroblast growth factor and its receptor by fibroblasts, macrophages and mast cells in hypertrophic scars. Eur J Dermatol 9: 357-362.
3. Appleton, I., N.J. Brown, D.A. Willoughby (1996) Apoptosis, necrosis, and proliferation: Possible implications in the etiology of keloids. Am J Pathol 149: 1441-1447.
4. Atamas, S.P. (2002) Complex cytokine regulation of tissue fibrosis. Life Sci 72: 631-643.
5. Babu, M., R. Diegelmann, N. Oliver (1989) Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 9: 1642-1650.
6. Boyce, D.E., J. Ciampolini, F. Ruge, M.S.C. Murison, K.G. Harding (2001) Inflammatory cell populations in keloid scars. Br J Plast Surg 54: 511-516.
7. Brogi, E., T. Wu, A. Namiki, J.M. Isner (1994) Indirect angiogenic cytokines upregulated VEGF and bFGF gene expression in vascular smooth muscle cells whereas hypoxia upregulates VEGF expression only. Circulation 90: 649-652.
8. Brown, L.F., B. Berse, R.W. Jackman, K. Tognazzi, E.J. Manseau, D.R. Senger, H.F. Dvorak (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-4735.
9. Brown, L.F., K. Yeo (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176: 1375-1379.
10. Connolly, D.T., D.M. Heuvelman, R. Nelson, J.V. Olander, B.L. Eppley, J.J. Delfino, N.R. Siegel, R.M. Leimgruber, J. Feder (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478.
11. Corral, C.J., A. Siddiqui, L. Wu, C.L. Farrell, D. Lyons, T.A. Mustoe (1999) Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 134: 200-205.
12. Cukierman, E., R. Pankov, D.R. Stevens, K.M. Yamada (2001) Taking cell-matrix adhesions to the third dimensions. Science 294: 1708-1712.
13. Daian, T., A. Ohtsuru, T. Rogounovitch, et al (2003) Insulin-like growth factor-I enhances transforming growth factor β-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts. J Invest Dermatol 120: 956-962.
14. Detmar, M., L.F. Brown, B. Berse, R.W. Jackman, B.M. Elicker, H.F. Dvorak, K.P. Claffey (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 108: 263-268.
15. Detmar, M., L.F. Brown, M.P. Schon, B.M. Elicker, P. Velasco, L. Richard, D. Fukumura, W. Monsky, K.P. Claffey, R.K. Jain (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111: 1-6.
16. Detmar, M., K.T. Yeo, J.A. Nagy, L. Van de Water, L.F. Brown, B. Berse, B.M. Elicker, S. Ledbetter, H.F. Dvorak (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105: 44-50.
17. Duncan, M.R., B. Berman (1991) Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin-6. J Invest Dermatol 97: 686-692.
18. Dvorak, H. (1986) Tumors: Wounds that do not heal. N Engl J Med 315: 1650.
19. Elson, D.A., H.E. Ryan, J.W. Snow, R. Johnson, J.M. Arbeit (2000) Coordinate up-regulation of hypoxia inducible factor (HIF)-1 alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res 60: 6189-6195.
20. Fava, R., N. Olsen, G. Spencer-Green, K. Yeo, B. Berse, R. Jackman, D. Senger, H. Dvorak, L. Brown (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180: 341-346.
21. Fattal, P.G., D.J. Schneider, B.E. Sobel, J.J. Billadello (1992) Post-transcriptional regulation of expression of plasminogen activator inhibitor-1 mRNA by insulin and insulin like growth factor-1. J Biol Chem 267: 12412-12415.
22. Ferrara, N., W.J. Henzel (1988) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858.
23. Forsythe, J.A., B.H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, R.D. Koos, G.L. Semenza (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
24. Frank, S., G. Hubner, G. Breier, M.T. Longaker, D.G. Greenhalgh, S. Werner (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 270: 12607-12613.
25. Frank, S., B. Stallmeyer, H. Kamper, N. Kolb, J. Pfeilschifter (1999) Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes and during cutaneous wound repair. FASEB J 13: 2002-2014.
26. Fukumura, D., R. Xavier, T. Sugiura, Y. Chen, E.C. Park, N. Lu, M. Selig, G. Nielsen, T. Taksir, R.K. Jain, B. Seed (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725.
27. Garbuzenko, E., A. Nagler, D. Pickholtz, P. Gillery, R. Reich, F.X. Maquart, F. Levi-Schaffer (2002) Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: A direct role for mast cells in skin fibrosis. Clin Exp Allergy 32: 237-246.
28. Higgins, P.J., J.K. Slack, R.F. Diegelmann, L. Staiano-Coico (1999) Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibric phenotype. Exp Cell Res 248: 634-642.
29. Houck, K.A., N. Ferrara (1991) The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814.
30. Howdieshell, T.R., D. Callaway, W.L. Webb, M.D. Gaines, C.D. Procter Jr., J.S.P. Sathyanarayana, T.L. Brock, P.L. McNeil (2001) Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96: 173-182.
31. Ihn, H., K. Tamaki (2000) Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J Immunol 165: 2149-2155.
32. Kischer, C.W. (1992) The microvessels in hypertrophic scars, keloids and related lesions: A review. J Submicrosc Cytol Pathol 24: 281-296.
33. Kischer, C.W., A.C. Thies, M. Chvapil (1982) Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 13: 819-824.
34. Knighton, D.R., V.D. Fiegel (1991) Regulation of cutaneous wound healing by growth factors and the microenvironment. Invest Radiol 26: 604-611.
35. Knighton, D.R., I.A. Silver, T.K. Hunt (1981) Regulation of wound healing angiogenesis effect of oxygen gradients and inspired oxygen concentration. Surgery 90: 262-270.
36. Lauer, G., S. Sollberg, M. Cole, I. Flamme, et al (2000) Expression and proteolysis of vascular endothelial growth factor is increased in chronic wound. J Invest Dermatol 115: 12-18.
37. Lee, T.Y., G.S. Chin, W.J. Kim, D. Chau, G.K. Gittes, M.T. Longaker (1999) Expression of transforming growth factor beta1, 2, and 3 proteins in keloids. Ann Plast Surg 43: 179-184.
38. Levy, A.P., N.S. Levy, M.A. Goldberg (1996) Posttranscriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271: 2746-2753.
39. Leung, D.W., G. Cachiances, W.J. Kuang (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
40. Liu, B., M.K. Connolly (1998) The pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg 17: 3-11.
41. Martin, P. (1997) Wound healing - Aiming for perfect skin regeneration. Science 276: 75-81.
42. Messadi, D.V., A. Le, S. Berg, P. Nguyen, G. Huang, W. Zhuang, C.N. Bertolami (1998) Effect of TGF-β1 on PDGF receptors expression in human scar fibroblasts. Front Biosci 3: a16-22.
43. Messadi, D.V., K. Sung-Cho, M. Lesavoy, S. Berg, C.N. Bertolami (1994) Autocrine TGF-β1 activity and glycosaminoglycan synthesis by human cutaneous fibroblasts. Wound Repair Regen 2: 284-291.
44. Minshall, E.M., D.Y. Leung, R.J. Martin, Y.L. Song, L. Cameron, P. Ernst, Q. Hamid (1997) Eosinophil-associated TGF-beta 1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 17: 326-333.
45. Murray, J.C. (1993) Scars and keloids. Dermatol Clin 11: 697-708.
46. Namiki, A., E. Brogi, M. Kearney, E.A. Kim, T. Wu, T. Couffinhal, L. Varticovski, J.M. Isner (1995) Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270: 31189-31195.
47. Nemeth, A.J. (1993) Keloid and hypertrophic scars. J Dermatol Surg Oncol 19: 738-746.
48. Niessen, F.B., P.H.M. Spauwen, J. Schalkwijk, M. Kon (1999) On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg 104: 1435-1458.
49. Nissen, N.N., P.J. Polverini, A.E. Koch, M.V. Volin, R.L. Gamelli, L.A. DiPietro (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152: 1445-1452.
50. Oloffson, B., E. Korpelainen, M.S. Peppers, S.J. Mandriota, K. Aase, V. Kumar, Y. Gunji, M.M. Jeltsch, M. Shibuya, K. Alitano (1998) Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 95: 11709-11714.
51. Pepper, M.S., N. Ferrara, L. Orci, R. Montesano (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181: 902-906.
52. Phan, T.T., I.J. Lim, B.H. Bay, R. Qi, M.T. Longaker, S.-T. Lee, H. Huynh (2003) Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived kereatinocytes in vitro. Am J Physiol Cell Physiol 284: C860-C869.
53. Plate, K.H., G. Breier, H.A. Weich, W. Risau (1992) Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359: 845-848.
54. Russsel, S.B., K.M. Trupin, S. Rodriguez-Eaton, J.D. Russel, J.S. Trupin (1988) Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 85: 587-591.
55. Sawdy, M.S., D.J. Loskutoff (1991) Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharides, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88: 1346-1353.
56. Semenza, G.L. (2002) Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64: 993-998.
57. Senger, D.R. (1993) Vascular permeability factor (VEP/VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324.
58. Shweiki, D., A. Itin, D. Soffer, E. Keshet (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845.
59. Steinbrech, D.S., M.T. Longaker, B.J. Mehrara, P.B. Saadeh, G.S. Chin, R.P. Gerrets, D.C. Chau, N.M. Rowe, G.K. Gittes (1999) Fibroblast response to hypoxia: The relationship between angiogenesis and matrix regulation. J Surg Res 84: 127-133.
60. Takeda, K., T. Ichiki, T. Tokunou, N. Iino, S. Fujii, A. Kitabatake, H. Shimokawa, A. Takeshita (2001) Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasmingen activator inhibitor-1 gene expression. Arterioscler Thromb Vasc Biol 21: 868-873.
61. Tang, W., G.P. Geba, T. Zheng, P. Ray, R.J. Homer, C. Kuhn, R.A. Flavell, J.A. Elias (1996) Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airway obstruction. J Clin Invest 98: 2845-2853.
62. Tuan, T.L., H.Y. Wu, E.Y. Hang, S.N. Chong, W. Laug, D.V. Messadi, P. Kelley, A. Le (2003) Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 162: 1579-1589.
63. Tuan, T.L., J.Y. Zhu, B. Sun, L.S. Nichter, M.E. Nimni, W.E. Laug (1996) Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 106: 1007-1011.
64. Uitto, J., D. Kouba (2000) Cytokine modulation of extracellular matrix gene expression: Relevance to fibrotic skin diseases. J Dermatol Sci 24: S60-S69.
65. Wu, Y., Z. Qunzhou, H. Duong, P. Kelly, D.V. Messadi, A.D. Le (2002a) Mechanisms of hypoxia-induced VEGF expression in keloids. J Dent Res 81: 1504.
66. Wu, Y., Q. Zhang, A.P. Kelly, D.V. Messadi, T.L. Tuan, A.D. Le (2002b) The involvement of hypoxia-inducible factor-1 in the regulation of plasminogen activator inhibitor type I promoter under hypoxia in human keloid fibroblasts. Mol Biol Cell 13: 205a.
67. Xue, H., R.L. McCauley, W. Zhang (2000) Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 89: 74-77.
68. Zhang, Q.Z., Y.D. Wu, D.K. Ann, D.V. Messadi, T.L. Tuan, A.P. Kelly, C.N. Bertolami, A.D. Le (2003a) Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol, in press.
69. Zhang, Q., Y. Wu, C. Chau, D. Ann, C.N. Bertolami, A.D. Le (2003b) Cross talk of hypoxia mediated signaling pathways in upregulation plasminogen activator inhibitor-1 expression in keloid fibroblasts. J Cell Physiol, in press.
70. Zhang, Q., Y. Wu, P. Kelly, D.V. Messadi, T.L. Tuan, A.D. Le (2002). Multiple signaling pathways involved in hypoxia upregulation of plasminogen activator inhibitor-1 gene in keloid fibroblasts. Mol Biol Cell 13: 206a.